X0306 4 2013-10-10 0001311230 SOLAZYME INC SZYM 0001353937 Licari Peter SOLAZYME, INC. 225 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Technology Officer Common Stock 2013-10-10 4 M 0 5500 2.35 A 260716 D Common Stock 2013-10-10 4 S 0 7000 11.0976 D 253716 D Employee Stock Option (right to buy) 2.35 2013-10-10 4 M 0 5500 0 D 2020-09-14 Common Stock 5500 73500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.18, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. All options immediately exercisable. The original option grant vests at a rate of 1/48 per month beginning September 15, 2010. /s/ Rob Maynes, as attorney-in-fact 2013-10-10